Skip to content

Multivitamin Support Following Bariatric Surgery

Functional Activity and Safety of a Food for Special Medical Purposes in Subjects Undergoing Bariatric Surgery: a Multicenter Prospective Observational Clinical Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06152965
Enrollment
20
Registered
2023-12-01
Start date
2021-04-26
Completion date
2023-02-27
Last updated
2023-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery

Keywords

VSG, RYGB, micronutrients deficiency

Brief summary

Bariatric surgery (BS), an effective treatment for severe obesity and its comorbidities, may result in micronutrient and vitamin deficiencies. This monocentric prospective observational study aimed at evaluating the efficacy of a specifically designed vitamin/mineral formula (Bariatrifast) for preventing and treating micronutrient deficiencies in patients submitted to BS.

Detailed description

Although BS effectively reduces body weight, improves metabolic alterations, and enhances overall health, it may also lead to micronutrients deficiency. This prospective observational study aimed at evaluating the effectiveness and safety of a specific FSMP (Food For Special Medical Purposes) in maintaining an adequate vitamin and micronutrient intake in patients with obesity submitted to VSG (Vertical Sleeve Gastrectomy) or RYGB (Roux-en-Y gastric bypass) . The included 20 consecutive patients with severe obesity who underwent BS (11 males, 9 females, all aged ≥18 years, with a BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 with at least one obesity-related comorbidity, followed for one year after surgery.

Interventions

None listed

Sponsors

Bioitalia srl
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* age \>18yrs * Written Informed consent done * Bariatric surgery done

Exclusion criteria

* alcool or drugs abuse * psychiatric illness * allergy

Design outcomes

Primary

MeasureTime frameDescription
Clinical efficacy of Bariatrifast on vitamins concentrationOne year. The study protocol included a presurgical visit (V0), and 4 follow up visits at 1 (V1), 3 (V2), 6 (V3), and 12 (V4) months after BS\*25-OH Vitamin D3 in microgram/Liter (mcg/L) and vitamin B12 in nanogram/Liter (ng/L)

Secondary

MeasureTime frameDescription
evaluation of other parameters from blood testOne year. The study protocol included a presurgical visit (V0), and 4 follow up visits at 1 (V1), 3 (V2), 6 (V3), and 12 (V4) months after BS* Blood counts: red blood cells in number per microliter (10\^6/microliter); hemoglobin in gram/liter (g/L); white blood cells in number per microliter (10\^3/microliter); platelets in number per microliter (10\^3/microliter) * ferritin in microgram/Liter (mcg/L), * ionized calcium in millimoles per liter (mmol/L), * PTH parathormone in nanogram/Liter (ng/L), * folic acid microgram/Liter (mcg/L), recorded at each visit
evaluation of body compositionOne year. The study protocol included a presurgical visit (V0), and 4 follow up visits at 1 (V1), 3 (V2), 6 (V3), and 12 (V4) months after BS\* Body weight (kilograms)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026